Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment

Cited by (297)

Items 101–200 of 297

1. Anti-Parkinson Effects of Holothuria leucospilota-Derived Palmitic Acid in Caenorhabditis elegans Model of Parkinson’s Disease
   Tanatcha Sanguanphun, Sukrit Promtang, Nilubon Sornkaew, Nakorn Niamnont, Prasert Sobhon, Krai Meemon · 2023 · Marine Drugs
2. Therapeutic genetic variation revealed in diverse Hsp104 homologs
   Zachary M. March, Katelyn M. Sweeney, Hanna Kim, Xiaohui Yan, Laura M. Castellano, Meredith E. Jackrel, JiaBei Lin, Edward Chuang, Edward Gomes, Corey W. Willicott et al. · 2020 · eLife
3. The role of alpha-synuclein in synucleinopathy: Impact on lipid regulation at mitochondria–ER membranes
   Peter A. Barbuti, Cristina Guardia‐Laguarta, Taekyung Yun, Zena K. Chatila, Xena E. Flowers, Chantel Wong, Bruno F. R. Santos, Simone B. Larsen, James S. Lotti, Nobutaka Hattori et al. · 2025 · npj Parkinson s Disease
4. Pathogenic Mechanisms of Cytosolic and Membrane-Enriched α-Synuclein Converge on Fatty Acid Homeostasis
   Arati Tripathi, Heba Alnakhala, Elizabeth Terry-Kantor, Andrew Newman, Lei Liu, Thibaut Imberdis, Saranna Fanning, Silke Nuber, Nagendran Ramalingam, Dennis Selkoe et al. · 2022 · Journal of Neuroscience
5. Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategy
   Saranna Fanning, Haley Cirka, Jennifer L. Thies, Jooyoung Jeong, Sarah M. Niemi, Joon Ho Yoon, Gary P. H. Ho, Julián Ávila-Pacheco, Ulf Dettmer, Lei Liu et al. · 2022 · npj Parkinson s Disease
6. Spen modulates lipid droplet content in adult Drosophila glial cells and protects against paraquat toxicity
   Victor Girard, Valérie Goubard, Matthieu Querenet, Laurent Seugnet, Laurent Pays, Serge Nataf, Eloïse Dufourd, David Cluet, Bertrand Mollereau, Nathalie Davoust · 2020 · Scientific Reports
7. Mitochondria-ER Tethering in Neurodegenerative Diseases
   Reza Raeisossadati, M Ferrari · 2020 · Cellular and Molecular Neurobiology
8. Defects of Nutrient Signaling and Autophagy in Neurodegeneration
   Jon Ondaro, Haizea Hernández-Eguiazu, Maddi Garciandia-Arcelus, Raúl Loera‐Valencia, Laura Rodríguez-Gómez, Andrés Jiménez-Zúñiga, Julen Goikolea, Patricia Rodriguez‐Rodriguez, Javier Ruiz‐Martínez, Fermín Moreno et al. · 2022 · Frontiers in Cell and Developmental Biology
9. APOE deficiency impacts neural differentiation and cholesterol biosynthesis in human iPSC-derived cerebral organoids
   Zhao, Jing, Ikezu, Tadafumi C., Lu, Wenyan, Macyczko, Jesse R., Li, Yonghe, Lewis-Tuffin, Laura J., Martens, Yuka A., Ren, Yingxue, Zhu, Yiyang, Asmann, Yan W. et al. · 2023 · Stem Cell Research & Therapy
10. Genetic Silencing of Fatty Acid Desaturases Modulates α-Synuclein Toxicity and Neuronal Loss in Parkinson-Like Models of C. elegans
    Malabika Maulik, Swarup Mitra, Ajiel Mae Basmayor, Brianna Lu, Barbara E. Taylor, Abel Bult‐Ito · 2019 · Frontiers in Aging Neuroscience
11. Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?
    Victoria Sidoroff, Pam Bower, Nadia Stefanova, Alessandra Fanciulli, Iva Stankovic, Werner H Poewe, Klaus Seppi, Gregor Karl Wenning, Florian Krismer · 2022 · Journal of Parkinson s Disease
12. Small molecule modulators of alpha-synuclein aggregation and toxicity: Pioneering an emerging arsenal against Parkinson’s disease
    Ishfaq Ahmad Ahanger, Tanveer Ali Dar · 2024 · Ageing Research Reviews
13. Small Molecules in Parkinson’s Disease Therapy: From Dopamine Pathways to New Emerging Targets
    Hwa‐Young Lee, Ahmed Elkamhawy, Polina Rakhalskaya, Qili Lu, Hossam Nada, Guofeng Quan, Kyeong Lee · 2024 · Pharmaceuticals
14. Genipin prevents alpha-synuclein aggregation and toxicity by affecting endocytosis, metabolism and lipid storage
    Rita Rosado-Ramos, Gonçalo M. Poças, Daniela Marques, Alexandre Foito, David Méndez Sevillano, Mafalda Lopes‐da‐Silva, Luís G. Gonçalves, Regina Menezes, Marcel Ottens, Derek Stewart et al. · 2023 · Nature Communications
15. Proteomics-Based Monitoring of Pathway Activity Reveals that Blocking Diacylglycerol Biosynthesis Rescues from Alpha-Synuclein Toxicity
    Martin Soste, Konstantina Charmpi, Fabienne Lampert, Juan Gerez, Marc van Oostrum, Liliana Malinovska, Paul J. Boersema, Natalia Cecilia Prymaczok, Roland Riek, Matthias Peter et al. · 2019 · Cell Systems
16. Extensive transcription mis-regulation and membrane defects in AdipoR2-deficient cells challenged with saturated fatty acids
    Mario Ruiz, Henrik Palmgren, Marcus Henricsson, Ranjan Devkota, Himjyot Jaiswal, Marcello Maresca, Mohammad Bohlooly‐Y, Xiaorong Peng, Jan Borén, Marc Pilon · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
17. Dynamic behaviors of α-synuclein and tau in the cellular context: New mechanistic insights and therapeutic opportunities in neurodegeneration
    Fred Yeboah, Taeeun Kim, Anke Bill, Ulf Dettmer · 2019 · Neurobiology of Disease
18. A crazy trio in Parkinson's disease: metabolism alteration, α-synuclein aggregation, and oxidative stress
    Sheng Li, Yanbing Liu, Sen Lu, Jiayi Xu, Xiaokun Liu, Di Yang, Yuxuan Yang, Lin Hou, Ning Li · 2024 · Molecular and Cellular Biochemistry
19. Validation of a multiplexed and targeted lipidomics assay for accurate quantification of lipidomes
    Nanyan Rena Zhang, Nathan Galen Hatcher, Kim Ekroos, Komal Kedia, Monika Kandebo, Jacob Marcus, Sean M. Smith, Kevin P. Bateman, Daniel S. Spellman · 2022 · Journal of Lipid Research
20. The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseases uncovers cholesterol as a regulator of astrocyte reactivity impaired by ApoE4
    Femke M. Feringa, Sascha Koppes-den Hertog, Lian Y. Wang, Rico J. E. Derks, Iris Daphne Kruijff, Lena Erlebach, Jorin Heijneman, Ricardo Miramontes, Nadine Pömpner, Niek Blomberg et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
21. Stearoyl-CoA desaturase-1: a potential therapeutic target for neurological disorders
    Melanie Loix, Sam Vanherle, Marta Turri, Stephan Kemp, Karl J. L. Fernandes, Jerome J. A. Hendriks, Jeroen F. J. Bogie · 2024 · Molecular Neurodegeneration
22. Lipid level alteration in human and cellular models of alpha synuclein mutations
    Hila Avisar, Cristina Guardia‐Laguarta, Matthew Surface, Nikolaos Papagiannakis, Matina Maniati, Roubina Ch. Antonelou, Dimitra A. Papadimitriou, Christos Koros, Aglaia Athanassiadou, Serge Przedborski et al. · 2022 · npj Parkinson s Disease
23. Patient-derived three-dimensional cortical neurospheres to model Parkinson’s disease
    Waseem Khan Raja, Esther Neves, Christopher Burke, Xin Jian Jiang, Ping Xu, Kenneth J. Rhodes, Vikram Khurana, Robert H. Scannevin, Chee Yeun Chung · 2022 · PLoS ONE
24. Parkin regulates neuronal lipid homeostasis through SREBP2-lipoprotein lipase pathway—implications for Parkinson’s disease
    Willcyn Tang, John Thundyil, Grace Gui Yin Lim, Teddy J. W. Tng, Sean Qing Zhang Yeow, Aditya Nair, Chou Chai, Tso‐Pang Yao, Kah‐Leong Lim · 2022 · Human Molecular Genetics
25. Lipids as the key to understanding α-synuclein behaviour in Parkinson disease
    Roni Stok Ranen, Avraham Ashkenazi · 2020 · Nature Reviews Molecular Cell Biology
26. Lipid profiling of Parkinson’s disease brain highlights disruption in Lysophosphatidylcholines, and triacylglycerol metabolism
    Ali Yılmaz, Nadia Ashrafi, Romana Ashrafi, Sümeyya Akyol, Nazia Saiyed, Ieva Kerševičiūtė, Miglė Gabrielaitė, Juozas Gordevičius, Stewart Francis Graham · 2025 · npj Parkinson s Disease
27. Free ferrous ions sustain activity of mammalian stearoyl-CoA desaturase-1
    Jiemin Shen, Gang Wu, Brad S. Pierce, Ah‐Lim Tsai, Ming Zhou · 2023 · Journal of Biological Chemistry
28. SCD Inhibition Protects from α-Synuclein-Induced Neurotoxicity But Is Toxic to Early Neuron Cultures
    Justin W. Nicholatos, Joost C. W. de Groot, Shekhar Dhokai, David T. Tran, Lori Hrdlicka, Thomas M. Carlile, Melissa Bennion, Isin Dalkilic-Liddle, Warren D. Hirst, Andreas Weihofen · 2021 · eNeuro
29. Reducing the lipase LIPE in mutant α-synuclein mice improves Parkinson-like deficits and reveals sex differences in fatty acid metabolism
    Marie-Alexandre Adom, Wolf N. Hahn, T.D. McCaffery, Tim E. Moors, X. Zhang, Per Svenningsson, Dennis J. Selkoe, Saranna Fanning, Silke Nuber · 2024 · Neurobiology of Disease
30. Targeting chaperone-mediated autophagy in neurodegenerative diseases: mechanisms and therapeutic potential
    Jin Wu, Wan Xu, Ying Su, Guanghui Wang, Jingjing Ma · 2024 · Acta Pharmacologica Sinica
31. Aberrant BCAA and glutamate metabolism linked to regional neurodegeneration in a mouse model of Leigh syndrome
    Karin Terburgh, Janeé Coetzer, Jeremie Zander Lindeque, Francois Hendrikus van der Westhuizen, Roan Louw · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
32. Multiomics approach identifies dysregulated lipidomic and proteomic networks in Parkinson’s disease patients mutated in TMEM175
    Federica Carrillo, Marco Ghirimoldi, Giorgio Fortunato, Nicole Piera Palomba, Laura Ianiro, Veronica De Giorgis, Shahzaib Khoso, Tiziana Giloni, Sara Pietracupa, Nicola Modugno et al. · 2025 · npj Parkinson s Disease
33. The Parkinson-Associated Toxin Paraquat Shifts Physiological α-Synuclein Tetramers toward Monomers That Can Be Calpain-Truncated and Form Oligomers
    Silke Nuber, Dennis J. Selkoe · 2023 · American Journal Of Pathology
34. Defining a Lewy Body: Running Up the Hill of Shifting Definitions and Evolving Concepts
    Tim E. Moors, Dragomir Milovanović · 2024 · Journal of Parkinson s Disease
35. Excess membrane binding of monomeric alpha-, beta- and gamma-synuclein is invariably associated with inclusion formation and toxicity
    Tae‐Eun Kim, Andrew J Newman, Thibaut Imberdis, Lisa Brontesi, Arati Tripathi, Nagendran Ramalingam, Saranna Fanning, Dennis J. Selkoe, Ulf Dettmer · 2021 · Human Molecular Genetics
36. Physiological and Metabolite Alterations Associated with Neuronal Signals of Caenorhabditis elegans during Cronobacter sakazakii Infections
    Muthubharathi Balasubramanian, Boopathi Balasubramaniam, Dilawar Ahmad Mir, V. Ravichandiran, Krishnaswamy Balamurugan · 2021 · ACS Chemical Neuroscience
37. Yeast models of neurodegenerative diseases
    Mick F. Tuite · 2019 · Progress in molecular biology and translational science
38. Mice defective in interferon signaling help distinguish between primary and secondary pathological pathways in a mouse model of neuronal forms of Gaucher disease
    Ayelet Vardi, Shifra Ben‐Dor, Soo Min Cho, Ulrich Kalinke, Julia Spanier, Anthony H. Futerman · 2020 · Journal of Neuroinflammation
39. Acetyl-CoA carboxylase activation disrupts iron homeostasis to drive ferroptosis
    Ziqi Han, Shuangyu Han, Xiaoyan Fang, Mengyu Lu, Yuanling Mao, Leilei Shi, Junxiu Song, Tian Wang, Jichen Xiao, Li Xiang et al. · 2025 · Free Radical Biology and Medicine
40. From pathogenesis to treatment: the emerging role of ferroptosis in Parkinson’s disease
    Ruoxin Tu, Zhongyu Han, Hongbo Zhang, Xiaoye Jia, Tong Sun, Hanlin Liu, Jingxian Li, Mi Tang, Shun Wang · 2025 · Frontiers in Immunology
41. Distinct domains in Ndc1 mediate its interaction with the Nup84 complex and the nuclear membrane
    Ingo Amm, Marion H Weberruss, Andrea Hellwig, Johannes Schwarz, Marianna Tatarek‐Nossol, Christian Lüchtenborg, Martina Kallas, Britta Brügger, Ed Hurt, Wolfram Antonin · 2023 · The Journal of Cell Biology
42. Discovery of plasma biomarkers for Parkinson's disease diagnoses based on metabolomics and lipidomics
    Xiaoxiao Wang, Bolun Wang, Fenfen Ji, Jie Yu Yan, Jiacheng Fang, Doudou Zhang, Ji Xu, Jing Ji, Xinran Hao, Hemi Luan et al. · 2024 · Chinese Chemical Letters
43. Ferrostatin-1 mitigates cellular damage in a ferroptosis-like environment in Caenorhabditis elegans
    Melisa Rut Ferreyra, Verónica L Romero, Lucía Eugenia Fernandez-Hubeid, Candelaria Gonzales-Moreno, Michael Aschner, Miriam B. Virgolini · 2024 · Toxicological Sciences
44. Novel approaches to counter protein aggregation pathology in Parkinson's disease
    Simon Stott, Richard K H Wyse, Patrik Brundin · 2019 · Progress in brain research
45. Parkinson disease is a fatty acidopathy
    Saranna Fanning, Dennis J. Selkoe · 2025 · Nature Reviews Neurology
46. Monomethyl branched-chain fatty acids are critical for Caenorhabitis elegans survival in elevated glucose conditions
    Andre F.C. Vieira, Mark A. Xatse, Hamide Tifeki, Cédric Diot, Albertha J.M. Walhout, Carissa Perez Olsen · 2021 · Journal of Biological Chemistry
47. The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines
    Laura J Smith, Magdalena M. Bolsinger, Kai‐Yin Chau, Matthew E. Gegg, Anthony H.V. Schapira · 2022 · Human Molecular Genetics
48. Generation of G51D and 3D mice reveals decreased α-synuclein tetramer-monomer ratios promote Parkinson’s disease phenotypes
    Silke Nuber, Xiaoqun Zhang, Thomas D. McCaffery, Tim E. Moors, Marie-Alexandre Adom, Wolf N. Hahn, Dylan Martin, Maria Ericsson, Arati Tripathi, Ulf Dettmer et al. · 2024 · npj Parkinson s Disease
49. Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson’s patients
    Laura de Boni, Amber Wallis, Aurelia Hays Watson, Alejandro Ruiz‐Riquelme, Louise‐Ann Leyland, Thomas Bourinaris, Naomi Hannaway, Ullrich Wüllner, Oliver Peters, Josef Priller et al. · 2024 · EMBO Molecular Medicine
50. Lipids and α-Synuclein: adding further variables to the equation
    Jana Schepers, Timo Löser, Christian Behl · 2024 · Frontiers in Molecular Biosciences
51. The Role of Astrocytes in Parkinson’s Disease
    Roger Garcia, Sara M. Zarate, Rahul Srinivasan · 2024 · Advances in neurobiology
52. Bioactive lipids and their metabolism: New therapeutic opportunities for Parkinson's disease
    Wenjing Shen, Li Jiang, Jingyi Zhao, Haili Wang, Meng Hu, Lanlan Chen, Yingzhu Chen · 2021 · European Journal of Neuroscience
53. A traffic jam leads to Lewy bodies
    Tim Bartels · 2019 · Nature Neuroscience
54. Targeting lipid metabolism in neurodegenerative diseases: From experimental to clinical
    Junpeng Long, Shasha Liu, Yaning Shi, Chanjuan Zhang, Qin Li, Qidi Ai · 2025 · Metabolism
55. Association of serum oleic acid level with depression in American adults: a cross-sectional study
    Jiahui Yin, Siyuan Li, Jinling Li, Rongpeng Gong, Zhixia Jia, Junjun Liu, Zhi Jin, Jiguo Yang, Yuanxiang Liu · 2023 · BMC Psychiatry
56. Lipid metabolism in health and disease: Mechanistic and therapeutic insights for Parkinson’s disease
    Bingqing Qin, Yuan Fu, Ana‐Caroline Raulin, Shuangyu Kong, Han Li, Junyi Liu, Chunfeng Liu, Jing Zhao · 2025 · Chinese Medical Journal
57. α-Synuclein and neuronal membranes: Conformational flexibilities in health and disease
    José Carlos Bozelli, Evelyn Rose Kamski‐Hennekam, Giuseppe Melacini, Richard M. Epand · 2021 · Chemistry and Physics of Lipids
58. Novel therapeutic approaches for Parkinson’s disease by targeting brain cholesterol homeostasis
    Tanvi Dayanand Pingale, Girdhari Lal Gupta · 2020 · Journal of Pharmacy and Pharmacology
59. Selective autophagy in type 2 diabetes-associated cognitive dysfunction: Insightful mechanisms and therapies
    Li Luo, Mengxin Que, Lian Zeng, Xuan Wang, Tianning Sun, Zhiqiang Zhou, Yilin Zhao, Shiyong Li, Ailin Luo · 2025 · Pharmacological Research
60. New Pieces for an Old Puzzle: Approaching Parkinson’s Disease from Translatable Animal Models, Gut Microbiota Modulation, and Lipidomics
    Lorena Ortega Moreno, Ana Bagüés, Vicente Martı́nez, Raquel Abalo · 2023 · Nutrients
61. MUFA synthesis and stearoyl-CoA desaturase as a new pharmacological target for modulation of lipid and alpha-synuclein interaction against Parkinson's disease synucleinopathy
    Joanna Kula, Katarzyna Z. Kuter · 2024 · Neuropharmacology
62. Lipidomics Reveals Dysregulated Glycerophospholipid Metabolism in the Corpus Striatum of Mice Treated with Cefepime
    Xiaocong Liu, Qingfan Wei, Xiaowei Yang, Xiaojie Wang, Jiamei Zhang, Rui Xu, Haoluo Zhang, Shaomin Wang, Xuemei Wan, Linhong Jiang et al. · 2021 · ACS Chemical Neuroscience
63. Integrated transcriptomic and metabolomic analysis of cortical neurons reveals dysregulated lipid metabolism, enhanced glycolysis and activated HIF-1 signaling pathways in acute hypoxia
    Wenyi Zhang, Bo Ram Han, Huijun Zhang, Rao Fu, Yinzhong Lu, Guangming Zhang · 2023 · Heliyon
64. Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies
    Chiara Sanluca, P. Spagnolo, Romina Mancinelli, Maria Ilenia De Bartolo, Marina Fava, Mauro Maccarrone, Simone Carotti, Eugenio Gaudio, Alessandro Leuti, Giorgio Vivacqua · 2024 · Metabolites
65. Stearoyl-CoA desaturase inhibition normalizes brain lipid saturation, α-synuclein homeostasis, and motor function in mutant Gba1-Parkinson mice
    Silke Nuber, Harrison W. Hsiang, Esraa F. Keewan, Tim E. Moors, Sydney J. Reitz, Anupama Tiwari, Gary P. H. Ho, Elena Su, Wolf N. Hahn, Marie-Alexandre Adom et al. · 2025 · JCI Insight
66. The interplay between lipid droplets and Parkinson's disease
    Xinru Zhao, Yingying Gu, Jiayi Wang, Ying Yi, Yan-qiu Zhang, Qian-Hang Shao, Mingxuan Liu, Xiaoling Zhang · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
67. Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models
    Angeliki Spathopoulou, Frank Edenhofer, Lisa Fellner · 2022 · Frontiers in Neurology
68. Nazo, the Drosophila homolog of the NBIA-mutated protein–c19orf12, is required for triglyceride homeostasis
    Perinthottathil Sreejith, Sara Lolo, Kristen R. Patten, Maduka Gunasinghe, Neya More, Leo J. Pallanck, Rajnish Bharadwaj · 2024 · PLoS Genetics
69. Uncovering the ferroptosis related mechanism of laduviglusib in the cell-type-specific targets of the striatum in Huntington’s disease
    Mei Liu, Jinlan Zhao, Chengcheng Xue, Jun Yang, Ying Li · 2024 · BMC Genomics
70. Transmembrane helices mediate the formation of a stable ternary complex of b5R, cyt b5, and SCD1
    Jiemin Shen, Gang Wu, Ah‐Lim Tsai, Ming Zhou · 2022 · Communications Biology
71. α-Synuclein acts as a cholesteryl-ester sensor on lipid droplets regulating organelle size and abundance
    Reeba Susan Jacob, Alessandro Dema, Hélène Chérot, Calvin Dumesnil, Shira Cohen, Hadas Sar Shalom, Nitzan Rimon, Odelia Sibony-Nevo, Gilad Beck, Elena Ainbinder et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
72. RXR nuclear receptor signaling modulates lipid metabolism and triggers lysosomal clearance of alpha-synuclein in neuronal models of synucleinopathy
    Arati Tripathi, Heba Alnakhala, Lisa Brontesi, Dennis J. Selkoe, Ulf Dettmer · 2024 · Cellular and Molecular Life Sciences
73. An Emerging Role for Phosphoinositides in the Pathophysiology of Parkinson’s Disease
    Meir Schechter, Ronit Sharon · 2021 · Journal of Parkinson s Disease
74. A high-resolution 13C NMR approach for profiling fatty acid unsaturation in lipid extracts and in live Caenorhabditis elegans
    Bruno Hernández Cravero, Gastón Prez, Verónica A. Lombardo, Florencia Guastaferri, Carla B Delprato, Silvia Altabe, Diego de Mendoza, Andrés Binolfi · 2024 · Journal of Lipid Research
75. Lipotoxicity Downstream of α-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?
    Arati Tripathi, Saranna Fanning, Ulf Dettmer · 2021 · Biomolecules
76. Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies
    Baoyi Li, Ulf Dettmer · 2024 · Neurobiology of Disease
77. Metabolic Dysregulation in Parkinson’s Disease: Non-Oxidative Phosphorylation and Its Role in Brain Energy Metabolism
    Marta M. Pokotylo, Norbert Brüggemann, Jannik Prasuhn · 2025 · Aging and Disease
78. Sterile innate immune mechanisms in neurodegenerative diseases
    Alyssa Ealy, Amanda M Serapiglia, Nikhil Panicker · 2025 · Journal of Biological Chemistry
79. Multi-omics insights into GBA1-associated Parkinson’s disease: interplay of genomics, transcriptomics, proteomics, and lipidomics
    Yang Ni, Huaibin Cai, Yaping Shao, Wei-Dong Le · 2026 · Molecular Neurodegeneration
80. Ultrastructures of α-Synuclein Filaments in Synucleinopathy Brains and Experimental Models
    Airi Tarutani, Masato Hasegawa · 2023 · Journal of Movement Disorders
81. Aggregation-induced emission luminogens for lipid droplet imaging
    Abdul Hakim Mohammad Mohsinul Reza, Yabin Zhou, Jianguang Qin, Youhong Tang · 2021 · Progress in molecular biology and translational science
82. REV-ERBα inhibitor rescues MPTP/MPP+-induced ferroptosis of dopaminergic neuron through regulating FASN/SCD1 signaling pathway
    Xiaoyu Wang, Mingmei Wang, Hui Zhi, Jingwei Li, Dongkai Guo · 2024 · Heliyon
83. iSCORE-PD: an isogenic stem cell collection to research Parkinson’s disease
    Oriol Busquets, Hanqin Li, Khaja Mohieddin Syed, Pilar Álvarez Jerez, Jesse Dunnack, Riana Lo Bu, Yogendra Verma, Gabriella Rita Pangilinan, Annika Martin, Jannes Straub et al. · 2026 · Nature Communications
84. Stem Cell-Based Approaches in Parkinson's Disease Research
    Min Seong Kim, Subeen Yoon, Jiwoo Choi, Yong Jun Kim, Gabsang Lee · 2024 · International Journal of Stem Cells
85. Aging AdipoR2 ‐deficient mice are hyperactive with enlarged brains excessively rich in saturated fatty acids
    Mario Ruiz, Ranjan Devkota, Per‐Olof Bergh, Ali Moussavi Nik, Sebastian Blid Sköldheden, Jorge Mondejar-Duran, Maximilian Tufvesson‐Alm, Mohammad Bohlooly‐Y, Diego Sánchez, Peter Carlsson et al. · 2024 · The FASEB Journal
86. Decoding Parkinson's disease – iPSC-derived models in the OMICs era
    Florian Krach, Marios Bogiongko, Beate Winner · 2020 · Molecular and Cellular Neuroscience
87. APOE genotypes differentially remodel the astrocytic lipid droplet-associated proteome to shape lipid droplet dynamics
    Carla Cuní‐López, Jessica T. Root, Ying Hao, Isabelle Kowal, Niek Blomberg, Rodolfo Ghirlando, Linda G. Yang, Sascha Koppes-den Hertog, Mark Cookson, Rik van der Kant et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
88. Increased burden of rare risk variants across gene expression networks predisposes to sporadic Parkinson’s disease
    Elena Eubanks, Katelyn VanderSleen, Jiya Mody, Neha Patel, Benjamin Sacks, Mahsa Darestanifarahani, Jinying Wang, Jordan Elliott, Nora S. Jaber, Fulya Akçimen et al. · 2025 · Cell Reports
89. Combining light-induced aggregation and biotin proximity labeling implicates endolysosomal proteins in early α-synuclein oligomerization
    Maxime Teixeira, Razan Sheta, Dylan Musiol, Vetso Ranjakasoa, Jérémy Loehr, Jean‐Philippe Lambert, Abid Oueslati · 2025 · iScience
90. Metabolic profiles associated with fat loss in Parkinson’s disease
    Atsuhiro Higashi, Yasuaki Mizutani, Reiko Ohdake, Yasuhiro Maeda, Junichiro Yoshimoto, Sayuri Shima, Yusuke Seino, Akihiro Ueda, Mizuki Ito, Atsushi Suzuki et al. · 2025 · Journal of Neurology Neurosurgery & Psychiatry
91. The effects of KTKEGV repeat motif and intervening ATVA sequence on α‐synuclein solubility and assembly
    Lisa Brontesi, Thibaut Imberdis, Nagendran Ramalingam, Ulf Dettmer · 2023 · Journal of Neurochemistry
92. Dysregulation of Monounsaturated Fatty Acids is Related to α‐Synuclein in Multiple System Atrophy
    Finula I. Isik, YuHong Fu, Russell Pickford, Qi Cheng, Yue Yang, Simon J.G. Lewis, Nicolas L. Dzamko, Glenda Margaret Halliday, Woojin Scott Kim · 2025 · Movement Disorders
93. The identification of novel schizophrenia-related metabolites using untargeted lipidomics
    Mengyao Shi, Xiangdong Du, Yiming Jia, Yonghong Zhang, Qiufang Jia, Xiaobin Zhang, Zhengbao Zhu · 2024 · Cerebral Cortex
94. Enhancing and Complementary Mechanisms of Synergistic Action of Acori Tatarinowii Rhizoma and Codonopsis Radix for Alzheimer’s Disease Based on Systems Pharmacology
    Shengwei Liu, Cui He, Yuan Liao, Hailin Liu, Wanli Mao, Zhengze Shen · 2020 · Evidence-based Complementary and Alternative Medicine
95. Astrocyte-Neuron Metabolic Synergies in Neurological Homeostasis and Disease
    Jiahao Dong, Zihan Gao, Mingrui Liu, Binglu Qian, Cheng Yuan, Hui Liu, Ni Rao, Yingjiao Liu · 2025 · Neurochemical Research
96. Central inhibition of stearoyl-CoA desaturase has minimal effects on the peripheral metabolic symptoms of the 3xTg Alzheimer’s disease mouse model
    Laura K. Hamilton, Paule E. H. M’Bra, Sophia Mailloux, Manon Galoppin, Anne Aumont, Karl J. L. Fernandes · 2024 · Scientific Reports
97. Studying Lipid-Related Pathophysiology Using the Yeast Model
    Tyler Ralph-Epps, Chisom Onu, Linh Vo, Michael W. Schmidtke, Anh Le, Miriam L. Greenberg · 2021 · Frontiers in Physiology
98. Clinical advances in analytical profiling of signature lipids: implications for severe non-communicable and neurodegenerative diseases
    Sutanu Sarkar, Deotima Roy, Bhaskar Chatterjee, Rajgourab Ghosh · 2024 · Metabolomics
99. Association of lipid levels with motor and cognitive function and decline in Parkinson's disease
    Lihua Gu, Hao Shu, Yanjuan Wang, Haonan Li, Pan Wang · 2024 · Psychogeriatrics
100. Sphingosine kinase-dependent regulation of pro-resolving lipid mediators in Alzheimer's disease
     Maria Ayub, Hee Kyung Jin, Jae‐sung Bae · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids